For people with diabetes, injecting insulin correctly is important to receive the full benefits of insulin therapy.2 However, in a recent observational study, all patients surveyed were making at least 1 injection technique error.3†
BD Nano™ 2nd Gen Pen Needles have a unique contoured base designed to compensate for a frequent injection error — using too much force when injecting.1,3*‡
Learn how to help patients inject correctly
Discover all the benefits of BD Nano™ 2nd Gen Pen Needles
Find tools to help you support patients with diabetes
More than 9 out of 10 health plans have coverage for embecta Pen Needles and Insulin Syringes.4
More than 9 out of 10 health plans have coverage for embecta Pen Needles and Insulin Syringes.4
Encourage patients to use a new needle with every injection
BD Nano™ 2nd Gen 4mm Pen Needle is estimated to reduce intramuscular (IM) injection risk by 2-8x using in-silico probability model of needle penetration depth for posted-hub pen needles of similar length and gauge and average human tissue thickness measurements across recommended injection sites, pooled across gender and BMI
N=230 patients with diabetes across Canada. Participants answered a survey as part of the cross-sectional observational behavioral study. BD helped fund this study.
Results from a survey of 230 Canadian patients with diabetes. 76% of patients reported applying excess pressure onto the skin when injecting.
References: 1. Rini C, Roberts BC, Morel D, et al. Evaluating the impact of human factors and pen needle design on insulin pen injection. J Diabetes Sci Technol. 2019;13(3):533-545. 2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2021;44(suppl 1):S1-S232. 3. Bari B, Corbeil MA, Farooqui H, et al. Insulin injection practices in a population of Canadians with diabetes: an observational study. Diabetes Ther. 2020;11(11):2595-2609. 4. Fingertip Formulary, as of 08/01/2023.